Larimar Therapeutics, Inc.(LRMR)

Biotechnology · Bala Cynwyd, PA

$2.81-0.05 (-1.79%)

Delayed quote: Oct 6, 2026, 2:15 PM EDT

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T18:17:41.363Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:17:41.363Z.

Quote observation: 2026-10-06T18:15:11.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 291,786,570
Total debt · period ending 2026-06-30: 4,956,000
Cash · period ending 2026-06-30: 92,687,000
TTM operating income · period ending 2026-06-30: -178,985,000

FMP input reference: 820e6844a86ebcce87b4cbc727545bf8fd5f2e7882f78b89935f6b0fc3bd738c

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

LRMR EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

LRMR Competitors' EV/EBIT Ratio

LRMR

Larimar Therapeutics, Inc.

Current

Market Cap

$291.79M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LAB

Standard BioTools Inc.

vs LRMR

Market Cap

$286.82M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ABEO

Abeona Therapeutics Inc.

vs LRMR

Market Cap

$285.83M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SGMT

Sagimet Biosciences Inc.

vs LRMR

Market Cap

$286.07M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INDP

Indaptus Therapeutics, Inc.

vs LRMR

Market Cap

$283.11M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BBOT

BridgeBio Oncology Therapeutics Inc.

vs LRMR

Market Cap

$283.18M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FULC

Fulcrum Therapeutics, Inc.

vs LRMR

Market Cap

$281.92M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACB

Aurora Cannabis Inc.

vs LRMR

Market Cap

$281.84M

EV/EBIT Ratio

N/A

TTM Avg

15.89x

3Y Avg

15.15x

5Y Avg

15.15x

MOBI

Mobia Medical, Inc. Common Stock

vs LRMR

Market Cap

$304.00M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BNTC

Benitec Biopharma Inc.

vs LRMR

Market Cap

$304.71M

EV/EBIT Ratio

N/A

TTM Avg

23.87x

3Y Avg

23.87x

5Y Avg

23.87x

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Larimar Therapeutics, Inc. (LRMR)	$291.79M	N/A	N/A	N/A	N/A
Standard BioTools Inc. (LAB)vs ›	$286.82M	N/A	N/A	N/A	N/A
Abeona Therapeutics Inc. (ABEO)vs ›	$285.83M	N/A	N/A	N/A	N/A
Sagimet Biosciences Inc. (SGMT)vs ›	$286.07M	N/A	N/A	N/A	N/A
Indaptus Therapeutics, Inc. (INDP)vs ›	$283.11M	N/A	N/A	N/A	N/A
BridgeBio Oncology Therapeutics Inc. (BBOT)vs ›	$283.18M	N/A	N/A	N/A	N/A
Fulcrum Therapeutics, Inc. (FULC)vs ›	$281.92M	N/A	N/A	N/A	N/A
Aurora Cannabis Inc. (ACB)vs ›	$281.84M	N/A	15.89x	15.15x	15.15x
Mobia Medical, Inc. Common Stock (MOBI)vs ›	$304.00M	N/A	N/A	N/A	N/A
Benitec Biopharma Inc. (BNTC)vs ›	$304.71M	N/A	23.87x	23.87x	23.87x

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

LRMR EV/EBIT Ratio Metrics

LRMR Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics